TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+14.35%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.65B
AUM Growth
+$2.65B
(+8.4%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
39.13%
Holding
181
New
13
Increased
25
Reduced
35
Closed
9
Top Buys
| 1 |
Eli Lilly
LLY
|
$17.7M |
| 2 |
Pfizer
PFE
|
$16.7M |
| 3 |
Biogen
BIIB
|
$13.8M |
| 4 |
McKesson
MCK
|
$12.3M |
| 5 |
Avantor
AVTR
|
$9.69M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$36.3M |
| 2 |
Johnson & Johnson
JNJ
|
$25.5M |
| 3 |
Humana
HUM
|
$18.1M |
| 4 |
AstraZeneca
AZN
|
$17M |
| 5 |
Molina Healthcare
MOH
|
$15.2M |
Sector Composition
| 1 | Healthcare | 97.55% |
| 2 | Real Estate | 1.68% |
| 3 | Industrials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Novartis
NVS
$245B
| $12.4M | 0.47% | 136,225 | – | – |
|
52
SPDR S&P Biotech ETF
XBI
$5.07B
| $12.3M | 0.46% | 147,677 | – | – |
|
53
Acadia Healthcare
ACHC
$2.12B
| $11.6M | 0.44% | 141,189 | – | – |
|
54
Rallybio
RLYB
$22.4M
| $11.3M | 0.43% | 1,727,067 -13,864 | -0.8% | -$91.1K |
|
55
Align Technology
ALGN
$10.3B
| $10.7M | 0.4% | 50,824 +31,930 | +169% | +$6.73M |
|
|
KRTX
56
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.5M | 0.4% | 53,452 +29,836 | +126% | +$5.86M |
|
57
Labcorp
LH
$23.1B
| $10.4M | 0.39% | 44,142 | – | – |
|
|
58
Avantor
AVTR
$9.18B
| $9.69M | 0.37% | +459,488 | New | +$9.69M |
|
|
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.12M | 0.34% | 172,371 | – | – |
|
60
Travere Therapeutics
TVTX
$1.56B
| $8.8M | 0.33% | 418,520 +170,842 | +69% | +$3.59M |
|
61
CVS Health
CVS
$92.8B
| $8.72M | 0.33% | 93,621 -30,182 | -24% | -$2.81M |
|
62
Omega Healthcare
OHI
$12.6B
| $8.56M | 0.32% | 306,433 | – | – |
|
63
Alkermes
ALKS
$4.78B
| $8.09M | 0.31% | 309,613 | – | – |
|
64
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.72M | 0.29% | 672,705 +323,135 | +92% | +$3.71M |
|
65
Denali Therapeutics
DNLI
$2.23B
| $7.58M | 0.29% | 272,520 +50,100 | +23% | +$1.39M |
|
|
MDRX
66
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.56M | 0.29% | 428,580 | – | – |
|
67
Elevance Health
ELV
$71.8B
| $7.51M | 0.28% | 14,644 | – | – |
|
68
HealthEquity
HQY
$7.72B
| $6.79M | 0.26% | 110,214 | – | – |
|
|
LTC
69
LTC Properties
LTC
$1.68B
| $6.48M | 0.24% | 182,293 | – | – |
|
70
Agilent Technologies
A
$35.7B
| $6.46M | 0.24% | 43,191 | – | – |
|
|
VECT
71
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $6.35M | 0.24% | 737,704 -18,798 | -2% | -$162K |
|
72
Sabra Healthcare REIT
SBRA
$4.58B
| $6.35M | 0.24% | 510,660 | – | – |
|
73
Sanofi
SNY
$121B
| $5.98M | 0.23% | 123,454 | – | – |
|
|
CTLT
74
DELISTED
CATALENT, INC.
CTLT
| $5.67M | 0.21% | +125,947 | New | +$5.67M |
|
|
CERE
75
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.57M | 0.21% | 176,483 | – | – |
|